König P, Hordvik N L, Kreutz C
J Allergy Clin Immunol. 1987 Jan;79(1):64-8. doi: 10.1016/s0091-6749(87)80018-0.
Nedocromil sodium, 4 mg, from a metered-dose inhaler, cromolyn sodium, (cr) 20 mg, from a Spinhaler, and placebo (pl) were compared in their efficacy and duration of action in preventing exercise-induced asthma. Twelve patients with asthma performed treadmill exercise tests 20 minutes, 2 hours, and 4 hours after a single dose of drug in a double-blind, crossover trial. Both active drugs were significantly better than pl at 20 minutes. Two hours after drug administration, only cr was significantly different from pl. The direct comparison between nedocromil and cr demonstrated no significant difference on FEV1, and the only significant difference was with forced expiratory flow between 25% and 75% of vital capacity at 2 hours. It is concluded that at these clinically recommended doses, both drugs are equally effective in preventing exercise-induced asthma with cr possibly having a somewhat longer duration of action.
在预防运动诱发性哮喘方面,对来自定量吸入器的4毫克奈多罗米钠、来自Spinhaler的20毫克色甘酸钠(cr)和安慰剂(pl)的疗效及作用持续时间进行了比较。在一项双盲交叉试验中,12名哮喘患者在单次给药后20分钟、2小时和4小时进行了跑步机运动测试。两种活性药物在20分钟时均显著优于安慰剂。给药2小时后,只有色甘酸钠与安慰剂有显著差异。奈多罗米与色甘酸钠的直接比较显示,在第1秒用力呼气量(FEV1)上无显著差异,唯一显著差异在于给药2小时时肺活量25%至75%之间的用力呼气流量。得出的结论是,在这些临床推荐剂量下,两种药物在预防运动诱发性哮喘方面同样有效,色甘酸钠的作用持续时间可能稍长一些。